As of January 18, 2023, Portugal had the highest COVID-19 vaccination rate in Europe having administered 272.78 doses per 100 people in the country, while Malta had administered 258.49 doses per 100. The UK was the first country in Europe to approve the Pfizer/BioNTech vaccine for widespread use and began inoculations on December 8, 2020, and so far have administered 224.04 doses per 100. At the latest data, Belgium had carried out 253.89 doses of vaccines per 100 population. Russia became the first country in the world to authorize a vaccine - named Sputnik V - for use in the fight against COVID-19 in August 2020. As of August 4, 2022, Russia had administered 127.3 doses per 100 people in the country.

The seven-day rate of cases across Europe shows an ongoing perspective of which countries are worst affected by the virus relative to their population. For further information about the coronavirus pandemic, please visit our dedicated Facts and Figures page.

The number of COVID-19 vaccination doses administered per 100 people in Sweden rose to 248 as of Oct 27 2023. This dataset includes a chart with historical data for Sweden Coronavirus Vaccination Rate.

The share of two year old children in Sweden who were covered by MMR vaccine (measles, mumps, and rubella) was relatively stable during the period from 2014 to 2021, at around ** percent. In 2021, the share two year old children vaccinated against MMR was **** percent.

Sweden SE: Immunization: Measles: % of Children Aged 12-23 Months data was reported at 97.000 % in 2016. This stayed constant from the previous number of 97.000 % for 2015. Sweden SE: Immunization: Measles: % of Children Aged 12-23 Months data is updated yearly, averaging 96.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 98.000 % in 2012 and a record low of 88.000 % in 1980. Sweden SE: Immunization: Measles: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Sweden – Table SE.World Bank: Health Statistics. Child immunization, measles, measures the percentage of children ages 12-23 months who received the measles vaccination before 12 months or at any time before the survey. A child is considered adequately immunized against measles after receiving one dose of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

Sweden: Percent of children ages 12-23 months with measles immunization: The latest value from 2022 is 92 percent, a decline from 97 percent in 2021. In comparison, the world average is 84 percent, based on data from 187 countries. Historically, the average for Sweden from 1980 to 2022 is 95 percent. The minimum value, 88 percent, was reached in 1980 while the maximum of 98 percent was recorded in 2012.

The share of *** year old children in Sweden who were vaccinated against polio slightly decreased during the period from 2014 to 2021. In 2021, **** percent of children were vaccinated against polio, down from a high of **** percent in 2014.

Immunization, measles (% of children ages 12-23 months) in Sweden was reported at 93 % in 2024, according to the World Bank collection of development indicators, compiled from officially recognized sources. Sweden - Immunization, measles (% of children ages 12-23 months) - actual values, historical data, forecasts and projections were sourced from the World Bank on November of 2025.

The increasing incidence of tick-borne encephalitis (TBE) in Sweden and several other European countries has sparked a discussion about the need for a public vaccination strategy. However, TBE vaccination coverage is incomplete and there is little knowledge about the factors influencing vaccination behavior. Based on a survey of 1,500 randomly selected respondents in Sweden, we estimate vaccination coverage in areas with different TBE risk levels and analyze the role of vaccine price and other factors influencing the demand for vaccination. First, we find that the average rate of TBE vaccination in Sweden is 33% in TBE risk areas and 18% elsewhere. Income, age and risk-related factors such as incidence of TBE in the area of residence, frequency of visits to areas with TBE risk, and experience with tick bites are positively associated with demand for TBE vaccine. Next, using contingent valuation methodology, we estimate the willingness to pay for TBE vaccination among the unvaccinated respondents and the effect of a possible subsidy. Among the unvaccinated respondents in TBE risk areas, we estimate the mean willingness to pay for the recommended three doses of TBE vaccine to be 465 SEK (approximately 46 euros or 40% of the current market price). We project that a subsidy making TBE vaccines free of charge could increase the vaccination rate in TBE risk areas to around 78%, with a larger effect on low-income households, whose current vaccination rate is only 15% in risk areas. However, price is not the only factor affecting demand. We find significant effects on vaccination behavior associated with trust in vaccine recommendations, perceptions about tick bite-related health risks and knowledge about ticks and tick-borne diseases. Hence, increasing knowledge and trust, as well as ease of access to vaccinations, can also be important measures for public health agencies that want to increase the vaccination rate.

The study estimates the willingness to pay (WTP) for TBE vaccination and the effect of a possible TBE vaccine subsidy on vaccination rates in Sweden. We also estimate the current vaccination coverage in areas differing in TBE incidence and analyze the role of income, risk behavior and other factors influencing vaccine demand.

Purpose:

To estimate the willingness to pay (WTP) for TBE vaccination and the effect of a possible TBE vaccine subsidy on vaccination rates in Sweden.

The data set contains the variables used in the study The Willingness to Pay for Vaccination against Tick-borne Encephalitis and Implications for Public Health Policy: Evidence from Sweden, published in PLOS ONE. The survey on Ticks, TBE and Lyme Disease contains additional questions not included in this dataset. The dataset are available for direct download in SPSS and Excel format.

The share of two year old children in Sweden who were covered by tuberculosis vaccine was fluctuating slightly during the period from 2014 to 2021. The lowest share was in 2015, when **** percent were vaccinated. In 2021, **** percent of two year old children were vaccinated against tuberculosis. The tuberculosis vaccine in Sweden is only recommended to certain groups.

Sweden SE: Immunization: DPT: % of Children Aged 12-23 Months data was reported at 98.000 % in 2016. This stayed constant from the previous number of 98.000 % for 2015. Sweden SE: Immunization: DPT: % of Children Aged 12-23 Months data is updated yearly, averaging 99.000 % from Dec 1980 (Median) to 2016, with 37 observations. The data reached an all-time high of 99.000 % in 2004 and a record low of 98.000 % in 2016. Sweden SE: Immunization: DPT: % of Children Aged 12-23 Months data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Sweden – Table SE.World Bank: Health Statistics. Child immunization, DPT, measures the percentage of children ages 12-23 months who received DPT vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized against diphtheria, pertussis (or whooping cough), and tetanus (DPT) after receiving three doses of vaccine.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

In the pre-vaccination era in Sweden, smallpox was estimated to have been responsible for 2,000 deaths per million people every year; in other terms, this meant that approximately 0.2 percent of the entire population (or one in every 500 people) would die of smallpox annually. From looking at other data sets, we know that this figure was as high as 7,200 deaths per million in some years, as individual epidemics regularly devastated large portions of the population. When Jenner's findings on vaccination were adopted by the scientific community in Europe, Sweden was one of the first countries to begin vaccinating infants on a large scale. This is reflected in the considerable decline of smallpox deaths in the early nineteenth century, where the number of deaths fell to just 623 annual smallpox deaths per million in the first decade. By the middle of the century, when vaccination was made compulsory by the Swedish government, it dropped even further, to less than ten percent of the pre-vaccination death rate. In the last two decades in the nineteenth century, when Swedish authorities began penalizing parents for not vaccinating their children, the smallpox death rate fell to just two deaths per million people, and Sweden reported its final endemic (naturally occurring) case of smallpox in 1895; making it the second country in the world (after Iceland in 1872) to successfully eradicate the disease.

Actual value and historical data chart for Sweden Immunization Pol3 Percent Of One Year Old Children

Sweden SE: Immunization: HepB3: % of One-Year-Old Children data was reported at 67.000 % in 2016. This stayed constant from the previous number of 67.000 % for 2015. Sweden SE: Immunization: HepB3: % of One-Year-Old Children data is updated yearly, averaging 67.000 % from Dec 2011 (Median) to 2016, with 6 observations. The data reached an all-time high of 67.000 % in 2016 and a record low of 42.000 % in 2011. Sweden SE: Immunization: HepB3: % of One-Year-Old Children data remains active status in CEIC and is reported by World Bank. The data is categorized under Global Database’s Sweden – Table SE.World Bank: Health Statistics. Child immunization rate, hepatitis B is the percentage of children ages 12-23 months who received hepatitis B vaccinations before 12 months or at any time before the survey. A child is considered adequately immunized after three doses.; ; WHO and UNICEF (http://www.who.int/immunization/monitoring_surveillance/en/).; Weighted average;

In 2022, around ** percent of the Swedish public thought vaccines were important for children. Although, a higher share thought vaccines were important in 2018 and 2020. Furthermore, the share who agreed vaccines were both safe and effective has also declined since 2020.

Actual value and historical data chart for Sweden Immunization Bcg Percent Of One Year Old Children

Dedicated to the work of the register-based large-scale national population study to monitor COVID-19 vaccination effectiveness and safety (RECOVAC) project.

Immunization, DPT (% of children ages 12-23 months) in Sweden was reported at 96 % in 2024, according to the World Bank collection of development indicators, compiled from officially recognized sources. Sweden - Immunization, DPT (% of children ages 12-23 months) - actual values, historical data, forecasts and projections were sourced from the World Bank on November of 2025.

Background & objectivesVaccine safety signals require investigation, which may be done rapidly at the population level using ecological studies, before embarking on hypothesis-testing studies. Incidence rates were used to assess a signal of narcolepsy following AS03-adjuvanted monovalent pandemic H1N1 (pH1N1) influenza vaccination among children and adolescents in Sweden and Finland in 2010. We explored the utility of ecological data to assess incidence of narcolepsy following exposure to pandemic H1N1 virus or vaccination in 10 sites that used different vaccines, adjuvants, and had varying vaccine coverage.MethodsWe calculated incidence rates of diagnosed narcolepsy for periods defined by influenza virus circulation and vaccination campaign dates, and used Poisson regression to estimate incidence rate ratios (IRRs) comparing the periods during which wild-type virus circulated and after the start of vaccination campaigns vs. the period prior to pH1N1 virus circulation. We used electronic health care data from Sweden, Denmark, the United Kingdom, Canada (3 provinces), Taiwan, Netherlands, and Spain (2 regions) from 2003 to 2013. We investigated interactions between age group and adjuvant in European sites and conducted a simulation study to investigate how vaccine coverage, age, and the interval from onset to diagnosis may impact the ability to detect safety signals.ResultsIncidence rates of narcolepsy varied by age, continent, and period. Only in Taiwan and Sweden were significant time-period-by-age-group interactions observed. Associations were found for children in Taiwan (following pH1N1 virus circulation) and Sweden (following vaccination). Simulations showed that the individual-level relative risk of narcolepsy was underestimated using ecological methods comparing post- vs. pre-vaccination periods; this effect was attenuated with higher vaccine coverage and a shorter interval from disease onset to diagnosis.ConclusionsEcological methods can be useful for vaccine safety assessment but the results are influenced by diagnostic delay and vaccine coverage. Because ecological methods assess risk at the population level, these methods should be treated as signal-generating methods and drawing conclusions regarding individual-level risk should be avoided.

In the eighteenth century, before vaccination was introduced to Sweden, smallpox epidemics were much more severe and regular than in the nineteenth century. Between 1774 and 1802, epidemics in Sweden peaked roughly every five years, with the toll reaching over seven thousand deaths per million people in some years. When vaccination was introduced to Sweden in the early 1800s, it greatly decreased the total number of smallpox deaths per million people, with the number never exceeding one thousand deaths per million people in any year after 1809. In actual numbers, there were roughly two thousand smallpox deaths per year in Sweden during the pre-vaccination era; optional vaccination helped bring this average down to 623 deaths between 1802 and 1811, while the number dropped to 176 between 1857 and 1866 when compulsory vaccination was introduced. Vaccination in Sweden became enforced in 1880, where parents were punished with fines or imprisonment for failing to immunize their child, and this helped bring the average number of smallpox deaths to just two deaths per year over the next two decades. Although there were some cases and fatalities recorded in the late 1890s, naturally occurring cases of smallpox were eliminated in Sweden in 1895, which made Sweden the second country in the world (after Iceland in 1872) to successfully eradicate the disease.